galanin(3-29) (pig)   Click here for help

GtoPdb Ligand ID: 6091

Comment: A synthetic fragment of endogenous porcine peptide galanin
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C)CC(C)C)Cc1ccc(cc1)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(CC)C)NC(=O)C(NC(=O)C(NC(=O)C1CCCN1C(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1ccc(cc1)O)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)N)CC(C)C)CC(=O)N)CO)C)CC(C)C)CC(C)C)Cc1nc[nH]c1)C)CC(=O)O)CC(=O)N)Cc1nc[nH]c1)CCCN=C(N)N)CO)Cc1ccccc1)Cc1nc[nH]c1)CC(=O)O
Isomeric SMILES CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
InChI InChI=1S/C133H199N39O39/c1-15-68(10)108(171-110(188)70(12)151-116(194)90(46-76-53-140-61-147-76)166-129(207)99-27-22-38-172(99)104(182)58-146-111(189)83(39-64(2)3)157-117(195)85(41-66(6)7)158-119(197)88(45-75-30-34-80(177)35-31-75)154-102(180)56-144-109(187)69(11)150-127(205)97(59-173)170-124(202)94(50-101(136)179)163-118(196)86(42-67(8)9)167-130(208)107(137)72(14)175)131(209)168-96(52-106(185)186)126(204)164-93(49-100(135)178)123(201)162-91(47-77-54-141-62-148-77)121(199)156-82(26-21-37-143-133(138)139)114(192)169-98(60-174)128(206)160-89(43-73-23-17-16-18-24-73)120(198)161-92(48-78-55-142-63-149-78)122(200)165-95(51-105(183)184)125(203)155-81(25-19-20-36-134)113(191)159-87(44-74-28-32-79(176)33-29-74)112(190)145-57-103(181)153-84(40-65(4)5)115(193)152-71(13)132(210)211/h16-18,23-24,28-35,53-55,61-72,81-99,107-108,173-177H,15,19-22,25-27,36-52,56-60,134,137H2,1-14H3,(H2,135,178)(H2,136,179)(H,140,147)(H,141,148)(H,142,149)(H,144,187)(H,145,190)(H,146,189)(H,150,205)(H,151,194)(H,152,193)(H,153,181)(H,154,180)(H,155,203)(H,156,199)(H,157,195)(H,158,197)(H,159,191)(H,160,206)(H,161,198)(H,162,201)(H,163,196)(H,164,204)(H,165,200)(H,166,207)(H,167,208)(H,168,209)(H,169,192)(H,170,202)(H,171,188)(H,183,184)(H,185,186)(H,210,211)(H4,138,139,143)/t68-,69-,70-,71-,72+,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,107-,108-/m0/s1
InChI Key LDEAEHIIHOWDLI-BQZNQBJUSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
GAL1 receptor Rn Agonist Agonist <6.0 pKi - 2,6-8
pKi <6.0 (Ki >1x10-6 M) [2,6-8]
GAL2 receptor Hs Agonist Agonist <6.0 pKi - 1
pKi <6.0 (Ki >1x10-6 M) [1]
GAL2 receptor Rn Agonist Agonist <6.0 pKi - 7-8
pKi <6.0 (Ki >1x10-6 M) [7-8]
GAL3 receptor Hs Agonist Agonist <6.0 pKi - 1,8
pKi <6.0 (Ki >1x10-6 M) [1,8]
GAL3 receptor Rn Agonist Agonist <6.0 pKi - 8
pKi <6.0 (Ki >1x10-6 M) [8]
GAL1 receptor Hs Agonist Agonist <5.0 – 6.0 pKi - 1,5
pKi <5.0 – 6.0 (Ki >1x10-5 – 1x10-6 M) [1,5]
GAL2 receptor Hs Agonist Agonist <6.0 pEC50 - 1
pEC50 <6.0 (EC50 >1x10-6 M) [1]
GAL2 receptor Rn Agonist Agonist <6.0 pEC50 - 7
pEC50 <6.0 (EC50 >1x10-6 M) [7]
GAL1 receptor Hs Agonist Agonist <6.0 pIC50 - 3
pIC50 <6.0 (IC50 >1x10-6 M) [3]
GAL2 receptor Hs Agonist Agonist <6.0 pIC50 - 3-4
pIC50 <6.0 (IC50 >1x10-6 M) [3-4]